Largest pharmaceutical companies in the United States by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

AbbVie leads the 44 pharmaceutical companies in the United States ranked by total liabilities, at £104.7B, ahead of Pfizer (£92.7B) and Johnson & Johnson (£89.8B). Figures as of 20 Nov 2026, 16:30 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
AbbVie£104.7B
Median
£635.8M
Combined market value
£2.88T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
GBP
Clear filters
Largest pharmaceutical companies in the United States by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health Care£104.7B£389.1B£220.13 1.69% up 20% up United States
2PfizerPFE · Health Care£92.7B£120.7B£21.17 0.71% up 10% up United States
3Johnson & JohnsonJNJ · Health Care£89.8B£499B£207.29 1.64% up 31% up United States
4Eli LillyLLY · Health Care£65.6B£920.7B£1,033.63 0.21% up 28% up United States
5Merck & CoMRK · Health Care£64.3B£254.9B£103.38 1.96% up 36% up United States
6Bristol-Myers SquibbBMY · Health Care£54.6B£92.9B£45.44 2.01% up 26% up United States
7Abbott LaboratoriesABT · Health Care£25.9B£137.9B£79.63 0.42% up 19% down United States
8ViatrisVTRS · Health Care£17.2B£17.2B£14.96 1.43% down 90% up United States
9ZoetisZTS · Health Care£9.3B£25.2B£62.12 0.72% up 34% down United States
10Royalty PharmaRPRX · Health Care£7.6B£30B£52.23 1.03% up 74% up United States
11Regeneron PharmaceuticalsREGN · Health Care£7.1B£73.7B£712.79 1.22% up 22% up United States
12Vertex PharmaceuticalsVRTX · Health Care£5.3B£101.6B£400.84 0.84% up 22% up United States
13Elanco Animal HealthELAN · Health Care£5.2B£9.9B£19.88 0.97% down 18% up United States
14Alnylam PharmaceuticalsALNY · Health Care£3.2B£15.3B£114.45 1.42% up 66% down United States
15Amneal PharmaceuticalsAMRX · Health Care£2.8B£5.6B£16.18 0.91% down 79% up United States
16PTC TherapeuticsPTCT · Health Care£2.4B£3.7B£44.08 1.00% down 26% down United States
17Ionis PharmaceuticalsIONS · Health Care£2.3B£3.5B£20.99 1.03% up 64% down United States
18BridgeBio PharmaBBIO · Health Care£2.3B£11.5B£59.04 1.09% down 15% up United States
19CytokineticsCYTK · Health Care£1.6B£5.5B£39.76 1.22% up 21% down United States
20InsmedINSM · Health Care£1.2B£24.3B£110.82 0.49% up 27% down United States
21BioMarin PharmaceuticalBMRN · Health Care£1.2B£9.1B£46.74 0.33% down 12% up United States
22Arrowhead PharmaceuticalsARWR · Health Care£673.3M£4.6B£32.84 1.47% down 8% up United States
23United TherapeuticsUTHR · Health Care£598.4M£18.1B£424.12 0.64% down 18% up United States
24Legend BiotechLEGN · Health Care£558.5M£2.3B£12.07 1.83% down 43% down United States
25Madrigal PharmaceuticalsMDGL · Health Care£501.5M£6.9B£297.91 1.64% down 28% down United States
26Axsome TherapeuticsAXSM · Health Care£459.2M£5.2B£99.63 3.82% down 9% down United States
27Ligand PharmaceuticalsLGND · Health Care£414.9M£4.4B£220.31 0.57% up 44% up United States
28Mirum PharmaceuticalsMIRM · Health Care£403.2M£4.9B£74.83 2.63% up 35% up United States
29Travere TherapeuticsTVTX · Health Care£374.4M£3.5B£36.87 0.00% 39% up United States
30TG TherapeuticsTGTX · Health Care£317M£7.4B£49.20 0.67% down 103% up United States
31Cogent BiosciencesCOGT · Health Care£230M£3.6B£20.56 2.94% down 25% down United States
32Rhythm PharmaceuticalsRYTM · Health Care£160.5M£6B£86.64 2.84% down 15% up United States
33Corcept TherapeuticsCORT · Health Care£144.2M£5.3B£48.59 2.06% down 16% down United States
34Definium TherapeuticsDFTX · Health Care£82.3M£3B£22.23 1.24% down 176% up United States
35Summit TherapeuticsSMMT · Health Care£70.5M£6.3B£7.83 2.93% down 35% down United States
36ErascaERAS · Health Care£54.2M£3.8B£10.74 1.09% down 387% up United States
37Spyre TherapeuticsSYRE · Health Care£47.7M£6.9B£72.79 2.34% down 302% up United States
38Praxis Precision MedicinesPRAX · Health Care£45.6M£6.5B£233.42 1.66% down 83% up United States
39Protagonist TherapeuticsPTGX · Health Care£40.8M£6.1B£93.56 1.18% down 45% up United States
40Dianthus TherapeuticsDNTH · Health Care£28.6M£3.6B£64.35 0.64% down 105% up United States
41Edgewise TherapeuticsEWTX · Health Care£23.2M£3.4B£30.84 1.89% down 82% up United States
42Oruka TherapeuticsORKA · Health Care£12.7M£4.8B£71.40 4.15% down 233% up United States
43Belite BioBLTE · Health Care£7.7M£4.1B£100.06 13.22% down 25% up United States
44VeradermicsMANE · Health Care£7M£3.9B£92.58 2.51% down 230% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7634 GBP).

Questions and answers

Which pharmaceutical companies in the United States rank first by total liabilities?

AbbVie (£104.7B), Pfizer (£92.7B) and Johnson & Johnson (£89.8B) are the top three of the 44 pharmaceutical companies in the United States ranked by total liabilities as of 20 Nov 2026, 16:30 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by total liabilities.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by total liabilities have a combined market value of £2.88T as of 20 Nov 2026, 16:30 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.